Armata (ARMP) Stock Surges 150% After Breakthrough Bacteriophage Trial Results
Armata’s stock performance this week has been nothing short of dramatic. Prior to Oct. 22, ARMP had been trading in the low-$3 range (for example, it closed around $3.41 on Oct. 16 marketbeat.com). Once the late-breaking IDWeek data was announced, the shares rocketed – briefly hitting an intraday high near $16 (per some quotes) before settling at about $8.87 finviz.com investing.com. For context, that $8.87 close is the stock’s highest level in years (FinViz shows a 52-week high of only $3.50 prior to today). By midday on Oct. 22, Investing.com already noted the stock was up ~95% on the day